Related Experiment Videos
Spinocerebellar degenerations: an update.
1Department of Neurology, UCLA School of Medicine, 300 UCLA Medical Plaza, Suite B200, Los Angeles, CA 90095, USA. sperlman@ucla.edu
Current Neurology and Neuroscience Reports
|June 5, 2002
Summary
Spinocerebellar degenerations are now understood with identifiable genetic causes, improving patient diagnosis and counseling. While treatments are gene-specific, current management focuses on symptom relief and rehabilitation.
Area of Science:
- Neurogenetics
- Neurology
- Molecular Diagnostics
Background:
- Spinocerebellar degenerations were once loosely defined phenotypes.
- Advances have led to identification of numerous genotypes.
Purpose of the Study:
- To review the progress in understanding spinocerebellar degenerations.
- To highlight the impact of molecular diagnostics on patient care.
Main Methods:
- Review of recent advancements in spinocerebellar degeneration research.
- Analysis of the role of molecular diagnostic tests.
Main Results:
- Spinocerebellar degenerations are now recognized as a disease family with many identified genotypes.
- Molecular diagnostic tests have simplified evaluation and enhanced patient/family counseling.
Conclusions:
- Gene-specific treatments are a promising future direction.
- Current management remains symptomatic, focusing on rehabilitation and empirical antioxidant use.